Update (09.03.2021): With the fast increase in the COVID-19 vaccine injections to the mass population, there is a strong belief that the situation is going to improve further. However, given the current situation, it will remain difficult to obtain travel documents and travel to Manchester this July (2021). The organisers have decided to hold the PSA conference during 4-6 July 2022, with further details to be released. We believe in the power of getting researchers together to inspire minds under one roof - this conference is here to serve this purpose.
Keep safe and well!
Jian R Lu
Dear friends and colleagues
Peptide research and development is fast expanding. The field of biomimetic and de novo designed peptides is particularly active, as it is embraced with many stimulating scientific challenges and potential technological benefits. Many new peptides are being reported, with novel structures, properties and functions.
Following the highly successful PSA Conference2018@Beijing, the Scientific Committee and conference attendees decided to hold the next one in Manchester, UK, to celebrate the collaborative and interdisciplinary nature of the peptide research across the globe. We warmly invite you to the exciting occasion next summer in Manchester.
The central theme of the conference is to transform knowledge into application through collaborative endeavours. We are organising an exciting Scientific Programme with topics ranging from peptide design and discovery, synthesis, characterisation, bionanomaterials, surface functionalisation, delivery vehicles, development of peptide therapeutics, to demonstrations and clinical assessments of antibacterial, anticancer and immune modulation peptides. The speakers invited will represent experts from both academia and industry.
As previously featured, we will continue to hold a young researchers session with short talks from PhD students, PDRAs and young industrial researchers, and mini-oral presentations featuring selected posters.
We look forward to seeing you in Manchester.
Jian R Lu, Xuehai Yan, Ehud Gazit and Junbai Li